Health policy has never looked so flirtatious. Every year, our readers send us valentines that make us swoon, laugh, and occasionally clutch our insurance cards. And in 2026, you did not hold back. You wrote about overcharging, rising insurance, AI in health care, and more. Here are some of our favorites, starting with the poem that stole…
Kyna Fong, Ph.D., Elation Health’s co-founder and CEO, says providers face issues of cost and complexity with EHR add-ons
Novartis already markets the PI3Kα inhibitor Piqray for breast cancer, but acquiring a Synnovation Therapeutics subsidiary brings an early clinical program that the pharma company claims could be best in the class of next-generation therapies for the target. Competitors include Eli Lilly, Relay Therapeutics, and OnKure Therapeutics. The post Why Novartis Is Paying $2B for…
Zenas Biopharma’s obexelimab achieved a statistically significant and clinically meaningful reduction in signs and symptoms of immunoglobulin G4-related disease, but not to the extent shown by Amgen’s Uplizna in its pivotal study. Still, Zenas points to features of its drug that could make it competitive as a maintenance therapy for the rare autoimmune disorder. The…
[Sponsored] At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch. The post The Human Algorithm: What AI Can’t Replace in Pharma Engagement appeared first on MedCity News.
By GEORGE BEAUREGARD This piece is different from the typical “health-care industry” topics covered in this forum. My Sunday morning routine usually involves getting a cup of coffee and downloading the most recent editions of magazines on my iPad. The cover of the February 13 edition of Time magazine immediately caught my attention because the…
Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products. The post Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis appeared first on MedCity News.
Check out news from Oral Genome, BeMe Health, Noetik, and Vouched. The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.
LISTEN: Is it worth it to set up a health savings account? HealthQ has answers. When Mike McKee thinks about saving money for the future, he has a few priorities. Maxing out his retirement is one. Building up his kid’s college fund is another. Opening up a health savings account? Not so much, even though…
The Trump administration must soon make a decision that will affect millions of Americans’ ability to access and afford mental health and addiction care. The administration is facing a May 12 deadline to declare if it will defend Biden-era regulations that aim to enforce mental health parity — the idea that insurers must cover mental…